233
Views
16
CrossRef citations to date
0
Altmetric
Methodology

The Cost-Effectiveness of Universal Varicella Vaccination in Italy: A Model-Based Assessment of Vaccination Strategies

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, , ORCID Icon, ORCID Icon & ORCID Icon show all
Pages 273-283 | Published online: 08 Jun 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Stephanie A. Kujawski, Colleen Burgess, Oren Agi, Zohar Attias-Geva, Matthew Pillsbury, David Greenberg, Goran Bencina & Manjiri Pawaskar. (2022) The health and economic impact of switching vaccines in universal varicella vaccination programs using a dynamic transmission model: An Israel case study. Human Vaccines & Immunotherapeutics 18:6.
Read now

Articles from other publishers (15)

Robert Anderson, Sungwook Kim, Nia Roberts & Stavros Petrou. (2023) Systematic review of economic evaluations of varicella vaccination programmes. PLOS ONE 18:3, pages e0282327.
Crossref
Huangyufei Feng, Haijun Zhang, Chao Ma, Haonan Zhang, Dapeng Yin & Hai Fang. (2023) National and provincial burden of varicella disease and cost-effectiveness of childhood varicella vaccination in China from 2019 to 2049: a modelling analysis. The Lancet Regional Health - Western Pacific 32, pages 100639.
Crossref
Elena Bozzola, Silvio Marchesani, Andrea Ficari, Carla Brusco, Giulia Spina, Maria Rosaria Marchili & Stefano Guolo. (2022) Assessing the use of antibiotics in pediatric patients hospitalized for varicella. Italian Journal of Pediatrics 48:1.
Crossref
Colleen Burgess, Stephanie Kujawski, Ajda Lapornik, Goran Bencina & Manjiri Pawaskar. (2022) The Long-Term Clinical and Economic Impact of Universal Varicella Vaccination in Slovenia. Journal of Health Economics and Outcomes Research, pages 95-102.
Crossref
Colleen Burgess, Stephanie Kujawski, Ajda Lapornik, Goran Bencina & Manjiri Pawaskar. (2022) The Long-Term Clinical and Economic Impact of Universal Varicella Vaccination in Slovenia. Journal of Health Economics and Outcomes Research 9:2.
Crossref
Oluwaseun Sharomi, Ilaria Xausa, Robert Nachbar, Matthew Pillsbury, Ian Matthews, Tanaz Petigara, Elamin Elbasha & Manjiri Pawaskar. (2022) Modeling the Impact of Exogenous Boosting and Universal Varicella Vaccination on the Clinical and Economic Burden of Varicella and Herpes Zoster in a Dynamic Population for England and Wales. Vaccines 10:9, pages 1416.
Crossref
Manjiri Pawaskar, Jaime Fergie, Carolyn Harley, Salome Samant, Phani Veeranki, Oliver Diaz & James H. Conway. (2022) Impact of universal varicella vaccination on the use and cost of antibiotics and antivirals for varicella management in the United States. PLOS ONE 17:6, pages e0269916.
Crossref
Matthew Pillsbury, Cristina Carias, Salome Samant, David Greenberg & Manjiri Pawaskar. (2022) Comparison of performance of varicella vaccines via infectious disease modeling. Vaccine 40:29, pages 3954-3962.
Crossref
Eric Yuk Fai Wan, Celine Sze Ling Chui, Yuan Wang, Vanessa Wai Sei Ng, Vincent Ka Chun Yan, Francisco Tsz Tsun Lai, Xue Li, Carlos King Ho Wong, Esther Wai Yin Chan, Christina Sze Man Wong, Kathy Sze Man Leung, Michael Yuxuan Ni, Sophie Alessandra Valkenburg, Joseph Sriyal Malik Peiris, Joseph Tsz Kei Wu, Benjamin John Cowling, Darren M Ashcroft, Ivan Fan Ngai Hung, Gabriel Matthew Leung & Ian Chi Kei Wong. (2022) Herpes zoster related hospitalization after inactivated (CoronaVac) and mRNA (BNT162b2) SARS-CoV-2 vaccination: A self-controlled case series and nested case-control study. The Lancet Regional Health - Western Pacific 21, pages 100393.
Crossref
Manjiri Pawaskar, Estelle Méroc, Salome Samant, Elmira Flem, Goran Bencina, Margarita Riera-Montes & Ulrich Heininger. (2021) Economic burden of varicella in Europe in the absence of universal varicella vaccination. BMC Public Health 21:1.
Crossref
Elena Bozzola, Giulia Spina, Maria Rosaria Marchili, Carla Brusco, Stefano Guolo, Chiara Rossetti, Giuseppe Logrieco, Francesca Pignatelli, Massimiliano Raponi & Alberto Villani. (2021) Pediatric Hospitalization for Varicella in an Italian Pediatric Hospital: How Much Does It Cost?. International Journal of Environmental Research and Public Health 18:22, pages 12053.
Crossref
Peeradone Srichan, Usa Thohinung, Salisa Kodyee & Tawatchai Apidechkul. (2021) Vaccine serocoverage under the expanded program on immunization among hill tribe children in Thailand: A cross-sectional study. Vaccine 39:44, pages 6477-6484.
Crossref
José Fontoura-Matias, Raquel Sofia Moreira, Ana Reis-Melo, Alberto Freitas & Inês Azevedo. (2021) Varicella Admissions in Children and Adolescents in Portugal: 2000–2015. Hospital Pediatrics 11:8, pages 856-864.
Crossref
Manjiri Pawaskar, Colleen Burgess, Mathew Pillsbury, Torbjørn Wisløff & Elmira Flem. (2021) Clinical and economic impact of universal varicella vaccination in Norway: A modeling study. PLOS ONE 16:7, pages e0254080.
Crossref
. (2020) Optimum varicella vaccine recommendation for Italy. PharmacoEconomics & Outcomes News 856:1, pages 23-23.
Crossref